ScripScan:Vivimed Labs ltd
Cmp:52
Traded in:Nse-bse
Story:Vivimed Labs Ltd was incorporated as a Private Limited company in 1989 and subsequently converted into a Public Limited Company.The company over the years has strategized, planned and moved into the activity of synthesis of "specialty chemicals" for end-use in Personal Care Industry. The company today has several products in this segment and has moved these products into over 20 countries across the globe.The company's manufacturing facilities have the required approvals from both domestic and international regulatory authorities. The company caters to marquee clients world wide. Today, it has a second lead position in the world in an anti-microbial product branded as "Viv20".Vivimed makes specialty chemicals such as Triclosan, an anti-bacterial that finds wide application in dental care and deodorants; Avis, which offers sunscreen protection; CaGP, an ingredient that finds application in dental care; Chlorophenesin, an anti-fungal that serves as a preservative in cosmetics and foodstuffs; and NDGA, an anti-oxidant.Vivimed labs has a coveted client base.Apart from Hindustan Lever, Vivimed also has customers such as Marico and Anchor Healthcare in the domestic market; Unilever, Arnaud of France and Harmet International of the US are some of its customers on the export market.Vivimed has been quite a consistent performer in the last few years.According to the management,"Earnings should continue because there are new products which are coming up, which have got better margins compared to the old quarter and the new products will have better margins.Vivimed labs currently is trading at an attractive valuations and scrip is expected to perform well over the coming 3-4 years.One can buy the scrip at dips for a 2year period horizion.
Search This Blog(Over 800 companies covered in the blog).
Please note
Archives : Old artciles
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
